from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2683/-

LFCtreatmentdescriptionclass of inhibitor

1.539

Amikacinug/mL Amikacintranslation

2.156

Cap5-10ug/mL Capreomycintranslation

2.012

Rox10-50 ug/mL Roxithromycintranslation

-0.017

SM2-5 ug/mL Streptomycintranslation

1.849

Tet5-10 ug/mL Tetracyclinetranslation

2.357

Rif0.2-5ug/mL Rifampicintranscription

0.704

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.053

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.344

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.375

CPZ10-50 ug/mL Chlorpromazinerespiration

0.337

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.305

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.464

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.452

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.659

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.555

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.127

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.621

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.227

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.261

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.199

KCN5-20 ug/mL Potassium cyaniderespiration

-0.054

NaN30.2-2 mM Sodium aziderespiration

0.464

Nigericin50 uM Nigericinrespiration

0.430

TRC10-150 ug/mL Triclosanrespiration

0.539

TRZ10-25 ug/mL Thioridazinerespiration

-0.736

Valinomycin0.5-10 uM Valinomycinrespiration

-0.129

ZnSO42 mM ZnSO4respiration

0.392

menadione6-10 ug/mL Menadionerespiration

0.101

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.548

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.371

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.242

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.314

NRP_1Non-replicating persistence stage 1dosRassociated

-0.138

Amp0.2mg/mL AmpicillincellWall

-0.150

Cephalexin20-100 ug/mL CephalexincellWall

-0.581

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.423

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.107

EMB10-20 ug/mL EthambutolcellWall

0.025

Eta12-40 ug/mL EthionamidecellWall

0.106

INH0.2-0.4 ug/mL IsoniazidcellWall

0.763

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.226

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.022

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.008

BZA0.12 mg/mL BenzamidearomaticAmides

-0.403

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.639

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.520

H2O24 mM hydrogen peroxideDNAdamaging

0.154

Levo10 ug/mL LevofloxacinDNAdamaging

-1.206

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.739

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.072

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.818

UVUV-irradiationDNAdamaging

1.311

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.370

Antimycin12.5-50 ug/mL Antimycin A?

0.326

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.647

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.160

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.348

PA8240.2-2 ug/mL PA-824?

-0.015

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.301

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.200

Verapamil50 uM Verapamil?

0.573

mercaptoethanol2 mM 2-Mercaptoethanol?

0.314

methoxatin10-20 ug/mL Methoxatin?